CN Patent

CN103626710A — 2-(5-溴-4-(4-环丙基萘-1-基)-4h-1，2，4-三唑-3-基硫基)乙酸的共晶及其制备方法

Assigned to SUZHOU PENGXU PHARMATECH Co Ltd · Expires 2014-03-12 · 12y expired

What this patent protects

本发明涉及化合物2-(5-溴-4-(4-环丙基萘-1-基)-4H-1，2，4-三唑-3-基硫基)乙酸的两种共晶型，分别涉及2-(5-溴-4-(4-环丙基萘-1-基)-4H-1，2，4-三唑-3-基硫基)乙酸-脯氨酸的共晶型A和2-(5-溴-4-(4-环丙基萘-1-基)-4H-1，2，4-三唑-3-基硫基)乙酸-乙醇酸的共晶型B。

USPTO Abstract

本发明涉及化合物2-(5-溴-4-(4-环丙基萘-1-基)-4H-1，2，4-三唑-3-基硫基)乙酸的两种共晶型，分别涉及2-(5-溴-4-(4-环丙基萘-1-基)-4H-1，2，4-三唑-3-基硫基)乙酸-脯氨酸的共晶型A和2-(5-溴-4-(4-环丙基萘-1-基)-4H-1，2，4-三唑-3-基硫基)乙酸-乙醇酸的共晶型B。

Drugs covered by this patent

Aloprim (ALLOPURINOL) · Casper Pharma Llc

Patent Metadata

Patent number: CN103626710A
Jurisdiction: CN
Classification: —
Expires: 2014-03-12
Drug substance claim: No
Drug product claim: No
Assignee: SUZHOU PENGXU PHARMATECH Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.